סרטיקן ® 0.25 מ"ג טבליות מסיסות

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

EVEROLIMUS 0.25 MG

Beschikbaar vanaf:

NOVARTIS PHARMA SERVICES AG

ATC-code:

L04AA18

farmaceutische vorm:

TABLETS DISPERSIBLE

Toedieningsweg:

PER OS

Geproduceerd door:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Therapeutische categorie:

EVEROLIMUS

therapeutische indicaties:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Autorisatie datum:

2010-02-01